Oct 11, 2016 | Inside, Research
After being inserted into a patient’s upper arm, this implantable device delivers low-level doses of buprenorphine for six months.
The U.S. Food and Drug Administration, following a nationwide clinical study by researchers at the Mount Sinai Health System, recently approved the first implantable form of buprenorphine—a drug used to treat opioid addiction. The implant, called Probuphine, delivers low-level doses of the medication for six months after being inserted under the skin on the inside of a patient’s upper arm. (more…)
Oct 11, 2016 | Inside, Research
Adriana Feder, MD, center, with Leah Cahn, LMSW, Clinical Social Worker, left, and Olivia Diab, Clinical Research Coordinator.
Fifteen years after the destruction of the World Trade Center, many first responders continue to grapple with health issues stemming from their work at Ground Zero, including those who report symptoms of posttraumatic stress disorder (PTSD).
In a recently published study in the Journal of Psychiatric Research, researchers led by Adriana Feder, MD, Associate Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai, found that police responders, who had more training and preparedness for disaster response, continued to maintain lower rates of elevated PTSD symptoms than construction workers or other “nontraditional” responders. Dr. Feder also serves as Associate Director for Research at the World Trade Center Mental Health Program at Mount Sinai. (more…)
Oct 6, 2016 | Inside
Dennis S. Charney, MD, delivers the State of the School address.
The Icahn School of Medicine at Mount Sinai honored eight renowned faculty members who have advanced the fields of cardiology, dermatology, health services, infectious diseases, pediatrics, psychiatry, and rehabilitation medicine during the 31st Annual Convocation Ceremony held Tuesday, September 27. The event marks the beginning of the academic year and features the annual State of the School address. (more…)
Oct 6, 2016 | Inside, Research, School
The agreement was signed by, from left: Kenneth L. Davis, MD, President and Chief Executive Officer, Mount Sinai Health System; Kenneth Kaushansky, MD, Dean of the Stony Brook University School of Medicine; and Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System.
The Icahn School of Medicine at Mount Sinai and the Stony Brook University School of Medicine have entered into an affiliation agreement that will build on a shared “culture of innovation” to enrich academic medicine programs and pursue breakthroughs in treating and understanding disease.
“Mount Sinai and Stony Brook bring unique strengths to this partnership,” says Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System. “Together we are committed to finding new ways to enhance academics and clinical care.” (more…)
Sep 17, 2016 | Community, Inside
Kravis Children’s Hospital at Mount Sinai, Garth Brooks and Band Visit to The Zone.
The country and pop music star Garth Brooks and his band members paid a special visit in July to the Child Life Zone at the Kravis Children’s Hospital at Mount Sinai to talk with pediatric patients and their families, play games, create artwork, and take photos. “The Zone,” which provides a fun and friendly environment for therapeutic and educational play activities, opened 10 years ago in partnership with the Garth Brooks Teammates for Kids Foundation and The Troy Aikman Foundation. Mr. Brooks and his band also appeared on a KidZone TV live broadcast, sharing stories and answering questions from pediatric patients in their hospital rooms. “The pure joy, energy, spirit, and warmth that Garth and the band brought to our children, teens, families, and staff was unparalleled,” says Diane Rode, Director, Child Life and Creative Arts Therapy Department, Kravis Children’s Hospital. “We are grateful every day for the power of ‘The Zone’ in helping us to humanize health care for our seriously ill children and their families.”
Sep 16, 2016 | Community, Inside
Neurosurgery patients at Mount Sinai Brooklyn can now receive in-depth evaluations, and local treatment in many cases, without having to travel into Manhattan. Ronit Gilad, MD, Chief of the Neurosurgical service at Mount Sinai Brooklyn, and Soriaya Motivala, MD, Co-Chief of the service, are leading the effort. Both are Assistant Professors of Neurosurgery at the Icahn School of Medicine at Mount Sinai and former Mount Sinai Neurosurgery residents. (more…)
